The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Waypoint Bio Appoints Dr. Patrick Kaifosh As Chief Technology Officer
PRIVATEJun 01, 2026•15 days ago
Position
Chief Technology Officer
Company
Waypoint Bio
Dr. Patrick Kaifosh
New YorkBiotechnologyHealth CareTherapeutics
Description
Waypoint Bio has appointed Dr. Patrick Kaifosh as Chief Technology Officer to strengthen its leadership in AI and automation. This appointment comes as the company secures a $20M Series A funding round to advance its AI-designed CAR T therapies.
Company Information
Company
Waypoint Bio
Location
New York, New York, United States
About
Waypoint Bio is a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology. The company's platform uniquely combines spatial biology with pooled screening for the purpose of drug discovery, enabling the simultaneous measurement of cell therapy candidates' navigation in the solid tumor microenvironment. Waypoint will use its seed financing toward designing CAR T-cell therapies with superior efficacy against the tumor microenvironment, and later, Treg therapies for autoimmune diseases.
New YorkBiotechnologyHealth CareTherapeutics